Document Detail


Effects of fungal statins on high-glucose-induced mouse mesangial cell hypocontractility may involve filamentous actin, t-complex polypeptide 1 subunit beta, and glucose regulated protein 78.
MedLine Citation:
PMID:  20627192     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Glomerular hyperfiltration is associated with mesangial cell hypocontractility. How 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) influence mesangial cell contraction is unclear. We investigated the effect of statins on mesangial cell hypocontractility and identified candidate proteins and filamentous/globular (F/G)-actin involved in this process. A high-glucose-induced mouse mesangial cell hypocontractility model was treated with fungal statins, simvastatin (Sim), lovastatin (Lov), and pravastatin (Pra). The optimum statin dose was determined by an 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay and then applied to a cell model. A 2-dimensional gel/matrix-assisted laser desorption/ionization time-of-flight mass spectrometer analysis was used to evaluate protein expression cells incubated in the presence of a normal level of glucose (N), a high level of glucose (H), and a high level of glucose plus Sim (H + S). Candidate proteins were analyzed. Finally, the ratio of F/G actin in groups N, H, and H+S was evaluated. The MTT assay showed that Sim and Lov exerted dose- and time-related inhibition of proliferation of mesangial cells at N, but Pra had no effect. The optimum doses selected for Sim was 1 microM and for Lov was 3 microM, which were 1 increment before significant proliferation inhibition. Both doses reversed cell hypocontractility significantly, but Sim was chosen for further proteomic and F/G actin analyses. Proteomic analysis of groups N, H, and H + S showed that 18 proteins were involved in hypocontractility. These proteins were grouped and analyzed based on their known functions. Two selected proteins, TCP-1beta and GRP78, that were upregulated and downregulated, respectively, were confirmed by Western blot and immunohistochemistry. In regard to the F/G actin, group H had a significantly lower ratio than that of group N, and group H + S returned to a level similar to that of group N. In conclusion, Sim and Lov both seem to reverse mesangial cell hypocontractility. The process of Sim reversal of mesangial cell hypocontractility may involve F-actin, TCP-1beta, and GRP78.
Authors:
Jyh-Chang Hwang; Li-Chien Chang; Yuh-Feng Lin; Hao-Ai Shui; Jin-Shuen Chen
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-19
Journal Detail:
Title:  Translational research : the journal of laboratory and clinical medicine     Volume:  156     ISSN:  1878-1810     ISO Abbreviation:  Transl Res     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-14     Completed Date:  2010-08-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101280339     Medline TA:  Transl Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  80-90     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) 2010 Mosby, Inc. All rights reserved.
Affiliation:
Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Actins / drug effects,  metabolism*
Acyl Coenzyme A / metabolism
Animals
Cell Division / drug effects
Glomerular Mesangium / cytology,  drug effects,  physiology*
Glucose / pharmacology*
Heat-Shock Proteins / drug effects,  metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
Kidney Glomerulus / drug effects,  physiology
Lovastatin / pharmacology
Mice
Pravastatin / pharmacology
Simvastatin / pharmacology*
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tetradecanoylphorbol Acetate / pharmacology
Chemical
Reg. No./Substance:
0/Actins; 0/Acyl Coenzyme A; 0/Heat-Shock Proteins; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/molecular chaperone GRP78; 1553-55-5/3-hydroxy-3-methylglutaryl-coenzyme A; 16561-29-8/Tetradecanoylphorbol Acetate; 50-99-7/Glucose; 75330-75-5/Lovastatin; 79902-63-9/Simvastatin; 81093-37-0/Pravastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplanta...
Next Document:  Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.